In the News

January 25, 2010

Freedom Meditech presents data showing benefits of non-invasive diabetes screening and glucose monitoring in the eye at a London conference. Read more >>>

November 13, 2009

Business Week features Freedom Meditech as 1 of the 25 Most Intriguing Start-Up Companies in the World. Read more >>>

October 13, 2009

Freedom Meditech's glucose monitoring technology successfully tested in pre-clinical trial. Read more >>>

October 12, 2009

Pharmawire's website featuring Freedom Meditech. Read more >>>

September 16, 2009

Freedom Meditech recieves $200,000 Working capital loan from City of Cleveland. Read more >>>

September 1, 2009

Start Up News features Freedom Meditech. Read more >>>

August 4,2009

Freedom Meditech,Inc secures second tranche of Series A Financing. Read more >>>

September 16,2008                                                                                                                                                             Freedom Meditech,Inc recieves Jumpstart Investment. Read more >>>

June 19, 2008
Freedom Meditech, Inc., completes Phase I of product development with Battelle; company staging for human clinical studies.  Read More >>>

Feb 15, 2008
Freedom Meditech, Inc., announces product development collaboration with Battelle. Company aligning resources for FDA clinical studies.  Read More >>>>  

Dec 15, 2007
Freedom Meditech, Inc., establishes R&D operations in Ohio. Plans to conduct final pre-clinical and 1st human study in Ohio. �Read More >>>

Oct. 15, 2007
Freedom Meditech, Inc., invited to speak at International Diabetes Technology Meeting in San Fransisco, California.  Data presented.

May 31, 2007
Freedom Meditech, Inc. secures additional angel financing.  Company prepares for additional pre-clinical studies. 

May 9, 2007
Freedom Meditech, Inc. agrees to terms with Dr. Daniel Einhorn, M.D. – now the fourth member of Freedom Meditech’s Scientific Advisory Board.  Dr. Daniel Einhorn’s research and publications cover diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies and pharmaceuticals, combination therapies, and clinical decision-making. �Read more >>>

April 25, 2007
Freedom Meditech, Inc. profiled in La Jolla Light.   Read more >>>

March 7, 2007
Freedom Meditech, Inc. CEO selected invited to present at the Frost and Sullivan’s 12th Annual Medical Devices 2007 Venture Connections Symposium.       Read more >>>

February 1, 2007
Freedom Meditech, Inc. announces the consummation of an exclusive, royalty bearing, worldwide license for the continued development and commercialization of a patent-pending non-invasive ocular glucose measurement technology for use by people with diabetes.          Read more >>>

January 4, 2007
Freedom Meditech, Inc. secures initial angel financing.  The capital is to be earmarked primarily for patent/legal expenditures, engineering costs, and other start-up operating capital needs.

December 26, 2006
Freedom Meditech, Inc. secures $500K line of credit from San Diego National Bank.  The line is to be used for short term operating capital needs.

December 18, 2006
Freedom Meditech, Inc. commences operations.  Headquarters established in San Diego, California.